Cipla's US sales are expected to be adversely impacted by price erosion and supply disruptions for tumor drug Lanreotide, ...

Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.

Mumbai: Cipla has announced that Rajeev Kumar Sinha, Global Chief Manufacturing Officer and Senior Management Personnel of ...

India's drug regulator identifies 135 drugs as 'not of standard quality' in December, including popular medications.

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state ...

The market may remain in positive terrain amid elevated volatility. Below are some trading ideas for the near term.

Most drugs found NSQ by central labs this month were produced in units located in cities such as Ahmedabad, Vadodara, ...

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

The S&P BSE Sensex was up 204.76 points to 76,725.14 at 9:17 am, while the NSE Nify50 was trading 64.15 points higher at ...

IST, the barometer index, the S&P BSE Sensex, shed 45.42 points or 0.07% to 76,474.96. The Nifty 50 index fell 20.60 points or 0.09% to 23,184.75.

After a rapid increase, benchmark indices Nifty and Sensex lost all their gains to trade mostly unchanged on the markets on ...